Global health has not figured prominently in the US presidential campaigns so far. Jobs and the economy are the major issues, and the weak growth in new jobs from the most recent report has done nothing to change that. And like all recent Presidential elections, this one is likely to be determined by voters in a small number of swing states.
The QDDR pre-release consultation document says the Global Health Initiative will eventually be managed by USAID. For a number of reasons, it makes complete sense for USAID to lead the GHI.
Since the Global Fund received $11.7 billion dollars in donor commitments for its next three years of programming, the media has focused on the over $1 billion dollar shortfall against the lowest resource scenario presented by the Fund in the lead up to its replenishment. Understandably so.
Secretary Hilary R. Clinton spoke yesterday at SAIS on the objectives of the Global Health Initiative (GHI). The webcast of the event provided a forum for an interesting and interested set of tweeters (I participated) to point out what we heard and did not hear during the talk.
Last week, the U.S. Senate Health, Education, Labor, & Pensions (HELP) Committee held a hearing that had all the elements of an important event for global health.
When you’ve had enough light summer reading about the unintended consequences of relaxing regulations of the offshore drilling industry or of the U.S.
House Energy and Commerce Committee Chair Henry Waxman (D-CA) and his staff are worried about something, and it’s not politics. The Energy and Commerce Subcommittee on Health is holding a series of hearings on antimicrobial resistance.
On Sunday the New York Times published four article on the battle against AIDS in Uganda which everyone should read who is interested in the AIDS epidemic, or in the effectiveness of US aid policy in general. The articles, all by the Times’ knowledgeable science reporter and long-time observer of the AIDS epidemic DonMcNeil, include:
Drug resistance finally got its day on Capitol Hill last week when the House Energy and Commerce Health Subcommittee held a hearing on the topic.
This is a joint post with Christina Droggitis and David Wendt.
The PEPFAR Strategy
PEPFAR marked this year’s World AIDS Day (Dec 1st) with the launch of their new five-year strategy. According to the press release, this document provides a high level policy framework (not a road map or implementation plan), outlining the general direction of PEPFAR in the next five-years. More specifically the strategy provides some insight into how PEPFAR will orient its approach to treatment, care and prevention and partnerships with country governments in the fight against AIDS. Of special note are the 5 key goals and specific targets (see page 6 of the strategy) that sets PEPFAR 2 apart from the previous phase of PEPFAR in the way that policy is being articulated.